Singapore: Amaran Biotechnology is going to invest $33.41 million (NT$1 billion) in order to construct a plant and a res...
Singapore: Australia-based Drawbridge Pharmaceuticals has commenced a phase 1C clinical trial of alphaxalone dissolved i...
Singapore: Australian company Clinuvel Pharmaceuticals reported successful, statistically significant results from its U...
Singapore: A pair of studies by researchers at the Stanford University School of Medicine has identified a molecular pat...
Singapore: Dr Deborah Rathjen, CEO of Australia based Bionomics, was awarded the Life Science Woman Executive of the Yea...
Singapore: A joint study by researchers at the National Neuroscience Institute (NNI), National University of Singapore (...
Singapore: BioDiem received a grant of a Chinese divisional patent, expanding the patent position for its novel antimicr...
Singapore: ChemoCentryx reported that GlaxoSmithKline's (GSK) first-of-four phase III studies, called Shield-1; investig...
Singapore: A research team led by Academia Sinica President, Dr. Chi-Huey Wong, and associate research fellow, Dr Chung-...
Singapore: Australia-based Phylogica recieved allowance of its US patent application for synthetic Phylomer libraries. T...
Singapore: Australian company Mesoblast has outlined the company's strategic plans to develop adult stem cell therapies...
Singapore: Bristol-Myers Squibb (BMS) has suspended study drug administration in an ongoing phase II study of BMS-986094...
Singapore: Australia-based Starpharma reported significant tumor-targeting results with its proprietary dendrimer-doceta...
Singapore: Eisai and Toyama Chemical have received approval from Japan's Ministry of Health, Labour and Welfare to marke...
Singapore: Jazz Pharmaceuticals reported earnings worth $208.3 million in revenue during the second quarter of 2013, an...
Singapore: Charles River Laboratories is soon to acquire CRO services division of Galapagos, which includes both Argenta...
Singapore: Tokyo-headquartered Chugai Pharmaceutical and Kyotobased Nippon Shinyaku have entered into an agreement to co...
Singapore: European Medicines Agency (EMA) has recommended granting a marketing authorization for Merck Sharp And Dohme'...
